In a similar manner to BRAF, mutationally activated RAS is reported to induce autophagy in a number of cancers [60,101,117], although the presence of a RAS mutation may not be predictive of sensitivity to chloroquine or other autophagy/lysosomotropic agents as it may be context-dependent [118,119]. This evidence concerns the gene BRAF and cancer.